Quotes Hansa Biopharma AB Mexican S.E.
Equities
HNSA N
SE0002148817
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
160.8 MXN | -.--% |
|
-.--% | -.--% |
Jun. 27 | Hansa Biopharma AB Announces Board Appointments | CI |
May. 31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
Volumes
marketsBasic data
Highs and lows
![Extreme 160.75](/images/extremecours_fleche.png)
![Extreme 160.75](/images/extremecours_fleche.png)
![Extreme 160.75](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -.--% | -.--% | -.--% | 331M | ||
-1.13% | +2.63% | +22.10% | -3.57% | 47.07B | ||
-0.50% | +3.15% | +46.45% | -2.96% | 42.06B | ||
+2.16% | +7.72% | -3.12% | +2.36% | 39.98B | ||
-0.20% | +3.78% | +36.10% | +29.03% | 33.02B | ||
+1.61% | +1.61% | -6.30% | +23.80% | 27.9B | ||
+0.55% | +4.76% | +18.71% | +38.20% | 27.63B | ||
-0.77% | +2.17% | +46.15% | +39.79% | 14.37B | ||
+1.84% | +10.09% | +44.52% | +83.19% | 13.45B | ||
+1.23% | +8.22% | +0.19% | -8.63% | 12.03B | ||
+2.52% | +8.28% | -8.55% | +2.46% | 10.86B | ||
+2.60% | +2.63% | -5.79% | -10.69% | 9.12B | ||
-0.01% | +5.44% | +27.69% | +97.68% | 7.38B | ||
+0.17% | -2.56% | +34.54% | +16.60% | 7.32B | ||
+4.13% | +20.28% | +57.39% | +67.56% | 7.15B | ||
+1.46% | +4.14% | -5.12% | +12.89% | 6.9B | ||
Average | +1.05% | +5.76% | +19.06% | +24.23% | ||
Weighted average by Cap. | +0.79% | +5.03% | +20.72% | +17.65% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
- Stock Market
- Equities
- HNSA Stock
- HNSA N Stock
- Quotes Hansa Biopharma AB